Drug Approval | December 23, 2022
Pregabalin Capsules have an estimated market size of US $244 million for twelve months ending Sep 2022 according to IQVIA
The balance of AUD 94 Million was a deferred consideration backed by a secured interest-bearing instrument
The project will generate and supply green energy to fulfill about 50% present consumption of the company
The expansion in Indore is well-aligned with Lupin Diagnostics’ commitment to improving access to high-quality, reliable, and advanced testing centres and home collection facilities at an affordable price
This FDC has been launched under the brand name Zita-PioMet, and contains Teneligliptin (20 mg) + Pioglitazone (15 mg) + Metformin (500mg/1000mg) in a sustained release (SR) formulation
The scheme is subject to statutory and regulatory approvals as may be necessary.
Indira IVF integrates diagnostics services with a special focus on women & child care to increase accessibility for patients
Ipca Laboratories now holds 58.88% of the paid-up equity share capital of the company.
Global pharmaceutical company having a surgical business concept incepted in Dubai
Subscribe To Our Newsletter & Stay Updated
